Outbreak of Francisella novicida bacteremia among inmates at a Louisiana correctional facility

Clinical Infectious Diseases

Volumn 59, Issue 6, 2014, Pages 826-833

  Brett, Meghan E ^a,b   Respicio Kingry, Laurel B ^b   Yendell, Stephanie ^a,b   Ratard, Raoult ^c   Hand, Julie ^c   Balsamo, Gary ^c   Scott Waldron, Christine ^c   O'Neal, Catherine ^d   Kidwell, Donna ^c   Yockey, Brook ^b   Singh, Preety ^e   Carpenter, Joseph ^b   Hill, Vincent ^a   Petersen, Jeannine M ^b   Mead, Paul ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c Louisiana Office of Public Health   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^e Louisiana Department of Education   (United States)

Author keywords

Francisella novicida; Ice; Outbreak; Prison

Indexed keywords

DRINKING WATER; HEPATITIS E VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PARACETAMOL; ANTIINFECTIVE AGENT; BACTERIAL DNA; RNA 16S;

ABDOMINAL PAIN; ACUTE LIVER FAILURE; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BANGLADESH; CHILD; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; EPIDEMIC; FEMALE; FEVER; HAND WASHING; HEADACHE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INFANT; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MATERNAL MORTALITY; MATERNAL WELFARE; NAUSEA; NEWBORN DEATH; PERINATAL MORTALITY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SEWAGE; SPONTANEOUS ABORTION; SURVIVOR; URBAN AREA; URBAN POPULATION; VOMITING; WATER CONTAMINATION; WATER SUPPLY; WEAKNESS; BACTEREMIA; CASE REPORT; CLASSIFICATION; COMORBIDITY; CROSS INFECTION; DNA SEQUENCE; FATALITY; FRANCISELLA; GENETICS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEALTH CARE FACILITY; MICROBIOLOGY; MIDDLE AGED; PHYLOGENY; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMORBIDITY; CROSS INFECTION; DISEASE OUTBREAKS; DNA, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; FATAL OUTCOME; FRANCISELLA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEALTH FACILITIES; HUMANS; LOUISIANA; MALE; MIDDLE AGED; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME;

EID: 84907408957     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu430     Document Type: Article

References (27)

1. Larson C, Wicht W, Jellison W. A new organism resembling P. tularensis isolated from water. Public Health Rep 1955; 70:253-8.
2. Johansson A, Celli J, Conlan W, et al. Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis. Int J Syst Evol Microbiol 2010; 60:1717-8; author reply 8-20.
3. Larsson P, Elfsmark D, Svensson K, et al. Molecular evolutionary consequences of niche restriction in Francisella tularensis, a facultative intracellular pathogen. PLoS Pathog 2009; 5:e1000472.
4. Barns SM, Grow CC, Okinaka RT, Keim P, Kuske CR. Detection of diverse new Francisella-like bacteria in environmental samples. Appl Environ Microbiol 2005; 71:5494-500.
5. Berrada ZL, Telford SR 3rd. Diversity of Francisella species in environmental samples from Martha's Vineyard, Massachusetts. Microb Ecol 2010; 59:277-83.
6. Kingry LC, Petersen JM. Comparative review of Francisella tularensis and Francisella novicida. Front Cell Infect Microbiol 2014; 4:35.
7. Birdsell DN, Stewart T, Vogler AJ, et al. Francisella tularensis subsp. novicida isolated from a human in Arizona. BMC Res Notes 2009; 2:223.
8. Brett M, Doppalapudi A, Respicio-Kingry LB, et al. Francisella novicida bacteremia after a near-drowning accident. J Clin Microbiol 2012; 50:2826-9.
9. Clarridge JE 3rd, Raich TJ, Sjosted A, et al. Characterization of two unusual clinically significant Francisella strains. J Clin Microbiol 1996; 34:1995-2000.
10. Hollis DG, Weaver RE, Steigerwalt AG, Wenger JD, Moss CW, Brenner DJ. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 1989; 27:1601-8.
11. Leelaporn A, Yongyod S, Limsrivanichakorn S, Yungyuen T, Kiratisin P. Francisella novicida bacteremia, Thailand. Emerg Infect Dis 2008; 14:1935-7.
12. Whitehouse CA, Kesterson KE, Duncan DD, Eshoo MW, Wolcott M. Identification and characterization of Francisella species from natural warm springs in Utah, USA. Lett Appl Microbiol 2012; 54:313-24.
13. Sjodin A, Svensson K, Ohrman C, et al. Genome characterisation of the genus Francisella reveals insight into similar evolutionary paths in pathogens of mammals and fish. BMC Genomics 2012; 13:268.
14. Versage JL, Severin DD, Chu MC, Petersen JM. Development of a multitarget real-time TaqMan PCR assay for enhanced detection of Francisella tularensis in complex specimens. J Clin Microbiol 2003; 41:5492-9.
15. Kugeler KJ, Mead PS, McGowan KL, et al. Isolation and characterization of a novel Francisella sp. from human cerebrospinal fluid and blood. J Clin Microbiol 2008; 46:2428-31.
16. Kugeler KJ, Pappert R, Zhou Y, Petersen JM. Real-time PCR for Francisella tularensis types A and B. Emerg Infect Dis 2006; 12:1799-801.
17. Staples JE, Kubota KA, Chalcraft LG, Mead PS, Petersen JM. Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. Emerg Infect Dis 2006; 12:1113-8.
18. Smith CM, Hill VR. Dead-end hollow-fiber ultrafiltration for recovery of diverse microbes from water. Appl Environ Microbiol 2009; 75:5284-9.
19. Fricker CR, Bullock S, Murrin K, Niemela SI. Use of the ISO 9308-1 procedure for the detection of E. coil in water utilizing two incubation temperatures and two confirmation procedures and comparison with defined substrate technology. J Water Health 2008; 6:389-97.
20. Petersen JM, Carlson J, Yockey B, et al. Direct isolation of Francisella spp. from environmental samples. Lett Appl Microbiol 2009; 48:663-7.
21. Forsman M, Sandstrom G, Sjostedt A. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol 1994; 44:38-46.
22. Nano FE, Zhang N, Cowley SC, et al. A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol 2004; 186:6430-6.
23. Cross JT, Jacobs RF. Tularemia: treatment failures with outpatient use of ceftriaxone. Clin Infect Dis 1993; 17:976-80.
24. Antunes NT, Frase H, Toth M, Vakulenko SB. The class A beta-lactamase FTU-1 is native to Francisella tularensis. Antimicrob Agents Chemother 2012; 56:666-71.
25. Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9:727-38.
26. Santic M, Molmeret M, Klose KE, Abu Kwaik Y. Francisella tularensis travels a novel, twisted road within macrophages. Trends Microbiol 2006; 14:37-44.
27. Cowley SC, Elkins KL. Immunity to Francisella. Front Microbiol 2011; 2:26.